EPISODE · Feb 15, 2022 · 43 MIN
Transformation in science, data and roles
from Lab to Lives
Send us Fan MailSam and Ivanna speak to Angela Slocum about the difficulty in quantifying the benefits of risk based monitoring when mostly you find no issues in your data. Angela does share an example of a fraudulent site being uncovered through risk based monitoring. We speak about how having experience from multiple clinical functions enables a unique platform for innovation when new demands arise but also when implementing software in the clinical space. We also dwell on managing change in our industry, and how conquering fear is vital even when working with highly skilled experts. “The science is so much more sophisticated than it used to be. There is much more data than there used to be. The data types and the amount of data are vast. And the roles and skills needed to support all that have evolved” Angela Slocum NotesGuest Angela Slocum: https://www.linkedin.com/in/angela-slocum-160b48126/ Risk-based monitoring (TransCelerate): https://www.transceleratebiopharmainc.com/rbminteractiveguide/what-is-risk-based-monitoring-rbm/introduction/ Technology mentioned: SAS JReview Spotfire EDCAI/ MLelluminateFunctions mentioned: Statistical Programming Data Management Clinical Operations Analytics Visit Labtolives.com Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/ Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/ Support the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn pageVisit www.labtolives.com HostsAlexander Booth aka the MedTech GuyDimitri Borisevich aka the start-up GuyIvanna Rosendal aka the R&D pharma Gal
NOW PLAYING
Transformation in science, data and roles
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m